Form 4 for VNRX VOLITIONRX LTD
Accepted 2021-11-03 00:00:00 ET · period of report 2021-11-01 · accession 0001477932-21-007790 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-11-03 | 2021-11-01 | VNRX | Plummer Nicholas | GC - Volition Diagnostics | A - Grant | $0.00 | +43.5K | 43.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-01 | A | A | 43,500 | $0.00 | 43,500 | D | — | — | (F1) In connection with his employment as General Counsel of Volition Diagnostics UK Limited, Mr. Plummer received restricted stock units subject to a 2-year vesting schedule, vesting as to 21,750 units on each of 11/01/22 and 11/01/23, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. |